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HPV Vaccination Among Adolescents 
and Adults in South Carolina
Introduction and Methods
The Centers for Disease Control and Prevention (CDC) 
recommends the Human Papillomavirus (HPV) vaccine 
routinely for all adolescents beginning at ages 11 to 
121. For those who start the vaccine series before 
their 15th birthday, two doses of the HPV vaccine are 
recommended. Adolescents and young adults (up to age 
26) who have not started or completed the HPV vaccine 
series by their 15th birthday need three doses1. This 
vaccine protects against both genital warts and cancers 
caused by HPV2. Studies have shown that the prevalence 
of HPV infection has decreased since the vaccine was 
introduced in 20063.
Although the HPV vaccine has been available for over 
ten years, immunization rates have not increased at 
the rate of other new vaccines, e.g., Tdap (Tetanus- 
Diptheria-Pertussis), both in South Carolina (SC) and 
the US4. Using the Children’s Health Assessment Survey 
(CHAS) and the Behavioral Risk Factor Surveillance 
System (BRFSS), demographic characteristics among 
adolescents and adults who received the HPV vaccine 
were examined in SC.
This report provides the most recent state estimates 
of HPV vaccination among adolescents (11–17 years) 
from CHAS (2012, 2014 and 2016) and among adults 
(18–35 years) from BRFSS (2015–2016) surveys in 
SC. The following characteristics among adults were 
included: race/ethnicity, sex, income, health insurance 
status, and Department of Health and Environmental 
Control (DHEC) region. The following characteristics 
among adolescents were included: age, race/ethnicity, 
sex, health insurance status, and DHEC region. Among 
adolescents, the sources from which parents/guardians 
heard about the HPV vaccine were also investigated. 
The data were weighted to represent all adolescents 
and adults in SC eligible for the vaccine.
SAS 9.4 software5 was utilized to obtain weighted 
prevalence estimates and 95% confidence intervals via 
survey analysis procedures.
Results
We found that 27% (± 4%) of adolescents (11–17 years) 
and 13% (± 1%) of adults (18–35 years) have received 
at least one dose of the HPV vaccine. Significantly 
more non- Hispanic blacks and females received the 
HPV vaccine compared to non-Hispanic whites and 
males among both adolescents and adults (Figure 1). 
Adults of lower (<$15K) annual household income had 
significantly higher HPV vaccination rates than those 
of higher ($50K+) income (17% vs. 10%). There were no 
significant differences by health insurance status, public 
health region, or adolescent’s age (data not shown).
Figure 1. Percent of adults and adolescents who have received 
at least one dose of HPV vaccine by sex and race/ethnicity (F: 
females; M: males; NHW: non-Hispanic white; NHB: non-Hispanic 
black; H: Hispanic; NHO: non-Hispanic other) 
*Adolescent Hispanic and non-Hispanic other estimates 
suppressed because confidence interval wider than 20%.
Approximately 83% of parents/guardians (of 
adolescents between ages 11–17) reported that they had 
heard of the HPV vaccine, and 55% of these parents/
guardians heard about it from their adolescent’s 
healthcare provider.
Among adolescents who received at least one dose, 80% 
of their parents/guardians heard about the HPV vaccine 
from the adolescent’s doctor (Figure 2).
Figure 2. Percent of adolescents who received at least one dose of 
HPV vaccine by where the parents/guardians heard about it
Parents/guardians reported several reasons for not 
vaccinating their adolescent, including the adolescent 
being too young (22%), concerns about the safety or 
side effects of the vaccine (12%), and because they did 
not think the adolescent needed the vaccine (11%).
Conclusions
For adolescents, our estimates agreed with national 
estimates that rank SC as the state with the second 
lowest HPV vaccine initiation6. There were no national 
estimates available for vaccination uptake in adults 
over 26 years of age, but, for ages 19–26, CDC estimates 
range from 2.1% to 48.5% based on the National Health 
Interview Survey7. We found a higher prevalence of HPV 
vaccination among females and non-Hispanic blacks 
compared to males and those of other racial/ethnic 
groups among both adolescents and adults in SC. These 
disparities by sex and race/ethnicity have also been 
observed nationally for adolescents6. 
The HPV vaccination is a form of primary cancer 
prevention, and the vaccine is recommended for all 
males and females ages 11–26 but may be given as 
early as age 91. Work is being done both on a state and 
national level to improve awareness and education 
regarding the importance of the HPV vaccine for 
adolescents and young adults through public health, 
health care and community partnerships. In SC, the HPV 
vaccine is available from health care provider offices, 
pharmacies and DHEC health departments.
A no-cost vaccine is available for eligible adolescents 
ages 9–18 (Vaccines for Children or SC State Vaccine 
Program from enrolled health care providers and  
DHEC health departments) and eligible adults  
age 19–26 (DHEC health departments). Visit  
www.scdhec.gov/scimmunize for more information.
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